NSE:ARISTO-SM

Aristo Bio-tech An · NSE · Basic Materials · INR · FY for 2026

Figures on this page computed 2026-11-08 13:41 UTC

Last close

n/aINR

Market data

9.4xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
INR
- computed
- Computed from the filing for 2026
26.8%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
2.0%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
INR
- Computed from the filing for 2026
- Computed from the filing for 2026
1.5%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
INR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.80Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
INR
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
INR
- computed

Safety is the furthest below its sector's middle: 0.35 against 0.56 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Ten years as a story

lens 9 of 9

We hold no filed year for this company, so there is nothing to read.

Nothing is drawn in its place. The other lenses are unaffected.